Performance analysis of TG Therapeutics (TGTX)
Annual Return
Over the past 3 years, TGTX has had an average annual return of +11.35%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, TGTX has had an average annual return of +1.24%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, TGTX has had an average annual return of +16.56%, outperforming the benchmark SPY, which returned +15.53% annual.
Since May 3, 2010, TGTX has had an average annual return of -10.67%, underperforming the benchmark SPY, which returned +14.14% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +22.87% | -0.97% | +76.28% | +44.30% | -37.68% | -63.49% | +368.97% | +170.88% | -50.00% | +75.85% | -60.94% | -24.72% |
| 2014 | 2013 | 2012 | 2011 | 2010 | |||||||
| +306.94% | +6.79% | +224% | -97.78% | -77.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -1.28% | +2.22% | +10.40% | +1.69% | +12.33% | -3.44% | +22.87% | ||||||
| 2025 | +5.31% | -5.11% | +31.04% | +15.47% | -22.89% | +2.56% | -1.37% | -17.36% | +23.16% | -3.74% | -4.40% | -10.35% | -0.97% |
| 2024 | -4.87% | +5.96% | -11.63% | -10.21% | +19.28% | +9.25% | +11% | +18.91% | -0.38% | +7.12% | +38.87% | -13.51% | +76.28% |
| 2023 | +28.71% | +5.17% | -6.18% | +65.27% | +7.25% | -6.76% | -16.67% | -49.46% | -20.00% | -7.53% | +65.41% | +33.39% | +44.30% |
| 2022 | -39.10% | -14.59% | -3.64% | -27.19% | -36.36% | -3.57% | +40.74% | +19.17% | -17.03% | -1.52% | +51.35% | +34.18% | -37.68% |
| 2021 | -7.22% | -9.32% | +10.13% | -7.24% | -21.99% | +11.23% | -9.80% | -22.64% | +22.94% | -6.15% | -51.30% | +24.85% | -63.49% |
| 2020 | +28.19% | -11.71% | -21.68% | +19.68% | +58.51% | +4.46% | +0.46% | +26.67% | +7.89% | -5.55% | +16.12% | +77.30% | +368.97% |
| 2019 | +0% | +65.93% | +18.21% | -1.12% | -20.96% | +37.63% | -13.28% | -17.12% | -9.42% | +21.60% | +19.74% | +35.44% | +170.88% |
| 2018 | +40.38% | +21.72% | +1.45% | +1.11% | -6.58% | -2.01% | -10.62% | +8.05% | -55.85% | -18.88% | +10.89% | -18.75% | -50.00% |
| 2017 | +2.90% | +18.78% | +104.74% | -5.21% | +1.83% | -10.60% | +14.32% | +10.37% | -6.56% | -31.31% | +5.52% | -4.71% | +75.85% |
Drawdown analysis of TG Therapeutics (TGTX)
The maximum drawdown for the TGTX was -99.52%, occurring on Dec 29, 2011. This drawdown has not yet recovered.
The current TGTX drawdown is -84.31%.
Since May 3, 2010 TGTX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.52% | May 4, 2010 | 419 | Dec 29, 2011 | Ongoing | Ongoing | Ongoing |